Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunru Lin

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|February 12, 2019
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney diseaseYajuan Li, Qingsong Hu, Chunlai Li, et al.
The Journal of Clinical Investigation|April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Cell Systems|March 12, 2018
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer ChronotherapyYouqiong Ye, Yu Xiang, Fatma Muge Ozguc, et al.
Genome Medicine|August 29, 2021
Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effectsYajuan Li, Yaohua Zhang, Qingsong Hu, et al.
Nature Cell Biology|January 24, 2017
A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasisChunlai Li, Shouyu Wang, Zhen Xing, et al.
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
Cell Research|January 12, 2019
LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transitionQingsong Hu, Chunlai Li, Shouyu Wang, et al.
Molecular Cancer|October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu, Yuan Li, Jiankang Jin, et al.
Nucleic Acids Research|October 12, 2020
Mechanism of efficient double-strand break repair by a long non-coding RNARoopa Thapar, Jing L Wang, Michal Hammel, et al.
Nature Cell Biology|January 12, 2016
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancerAifu Lin, Chunlai Li, Zhen Xing, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|February 12, 2019
PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney diseaseYajuan Li, Qingsong Hu, Chunlai Li, et al.
The Journal of Clinical Investigation|April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisZhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Cell Systems|March 12, 2018
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer ChronotherapyYouqiong Ye, Yu Xiang, Fatma Muge Ozguc, et al.
Genome Medicine|August 29, 2021
Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effectsYajuan Li, Yaohua Zhang, Qingsong Hu, et al.
Nature Cell Biology|January 24, 2017
A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasisChunlai Li, Shouyu Wang, Zhen Xing, et al.
Innovation (Cambridge (Mass.))|January 3, 2022
Profiling of immune features to predict immunotherapy efficacyYouqiong Ye, Yongchang Zhang, Nong Yang, et al.
Cell Research|January 12, 2019
LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transitionQingsong Hu, Chunlai Li, Shouyu Wang, et al.
Molecular Cancer|October 12, 2019
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinomaYan Xu, Yuan Li, Jiankang Jin, et al.
Nucleic Acids Research|October 12, 2020
Mechanism of efficient double-strand break repair by a long non-coding RNARoopa Thapar, Jing L Wang, Michal Hammel, et al.
Nature Cell Biology|January 12, 2016
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancerAifu Lin, Chunlai Li, Zhen Xing, et al.
Pageof 7